BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1456@azbio.org DTSTART;TZID=America/Phoenix:20200430T103000 DTEND;TZID=America/Phoenix:20200430T113000 DTSTAMP:20200420T171951Z URL:https://www.azbio.org/events/testing-the-key-to-getting-to-the-end-of- the-covid-19-health-emergency SUMMARY:Testing: The Key to Getting to the End of the COVID-19 Health Emerg ency - Webinar - 30 Apr 20 10:30 DESCRIPTION:Testing:\nThe Key to Getting to the End of the COVID-19 Health Emergency\n \;\n\nJoin us for a virtual meeting and discussion with Ma ra G. Aspinall of BlueStone Venture Partners as we explore where we have b een where we are\, and where we need to get to so that we can bring this h ealth emergency to an end. \;\n\nDate: \; Thursday\, April 30\, 20 20\n\nTime: \; 10:30 AM - 11:30 AM\n\n\n\nAccess information will be p rovided via email following registration.\n\n \;\n\n\n\nMara \; G. Aspinall is a healthcare industry leader and pioneer committed to active civic involvement. She is Managing Director and Co-Founder of BlueStone Ve nture Partners\, a venture fund investing in life sciences technology comp anies in the US Southwest. She is also CEO of the Health Catalysts Group\, a consulting firm dedicated to the growth of health information technolog y and diagnostics firms\, publishing the popular \;Health Catalysts Di agnostics Year in Review. She is a member of the Board of Directors of Abc am plc (ABC)\, Allscripts (MDRX)\, Castle Biosciences (CSTL)\, Orasure (OS UR)\, and Blue Cross Blue Shield Arizona.\n\nMost recently\, Aspinall was certified in Cybersecurity Oversight from Carnegie Mellon University.\n\nP rior to founding BlueStone\, Aspinall had extensive experience in the risk -based capital industry. \; She has served as advisor on life sciences transactions for large venture capital and private equity firms.  \;A t BCBS Arizona\, Aspinall chaired the Board of their strategic corporate v enture fund\, Trinnovate Ventures. \;\n\nAs President and CEO of Venta na Medical Systems\, a billion-dollar division of The Roche Group\, (now R oche Tissue Diagnostics) Aspinall led her world-class team to new financia l success\, more than two dozen major instrument and assay launches as wel l as global leadership in companion diagnostics. \;\n\nPreviously\, sh e served as President of Genzyme Genetics and Genzyme Pharmaceuticals. Gen zyme Genetics grew into the country’s leading diagnostic testing company and was sold to LabCorp for $1 billion.\n\n \; MORE\n\n \;\n\n&nb sp\; CATEGORIES:webinars LOCATION:Webinar\, Anywhere\, USA\, United States X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Anywhere\, USA\, United Sta tes;X-APPLE-RADIUS=100;X-TITLE=Webinar:geo:0,0 END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20190501T103000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR